StonvexLoading…
StonvexStonvexStonvexCore line items from CLSK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2020 2020-09-30 | Annual 2019 2019-09-30 |
|---|---|---|
Revenue | $8.62M | $3.75M |
Operating Income | $-15.14M | $-16.61M |
Net Income | $-23.35M | $-26.12M |
EPS (Diluted) | Not available | $-6.25 |
Total Assets | $22.34M | $23.43M |
Total Liabilities | $5.91M | $4.55M |
Cash & Equivalents | $3.13M | $7.84M |
Free Cash Flow OCF − CapEx | $-6.68M | $-5.80M |
Shares Outstanding | 17.39M | 4.68M |